Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP578918.RApsiWdr-kEHlbN0YVa6bMGQSw7Y0Iz-SKA22OSjDvhNI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP578918.RApsiWdr-kEHlbN0YVa6bMGQSw7Y0Iz-SKA22OSjDvhNI130_assertion type Assertion NP578918.RApsiWdr-kEHlbN0YVa6bMGQSw7Y0Iz-SKA22OSjDvhNI130_head.
- NP578918.RApsiWdr-kEHlbN0YVa6bMGQSw7Y0Iz-SKA22OSjDvhNI130_assertion description "[Gene-specific quantitative multiplex polymerase chain reaction of candidate oncogenes at 1q32.1 (KIF14), 6p22 (E2F3 and DEK), and tumor suppressor genes at 16q22 (CDH11) and 17q21 (NGFR) showed the most common gene gains in RB to be KIF14 in cell lines (80%) and E2F3 in primary tumors (70%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578918.RApsiWdr-kEHlbN0YVa6bMGQSw7Y0Iz-SKA22OSjDvhNI130_provenance.
- NP578918.RApsiWdr-kEHlbN0YVa6bMGQSw7Y0Iz-SKA22OSjDvhNI130_assertion evidence source_evidence_literature NP578918.RApsiWdr-kEHlbN0YVa6bMGQSw7Y0Iz-SKA22OSjDvhNI130_provenance.
- NP578918.RApsiWdr-kEHlbN0YVa6bMGQSw7Y0Iz-SKA22OSjDvhNI130_assertion SIO_000772 17099872 NP578918.RApsiWdr-kEHlbN0YVa6bMGQSw7Y0Iz-SKA22OSjDvhNI130_provenance.
- NP578918.RApsiWdr-kEHlbN0YVa6bMGQSw7Y0Iz-SKA22OSjDvhNI130_assertion wasDerivedFrom befree-2016 NP578918.RApsiWdr-kEHlbN0YVa6bMGQSw7Y0Iz-SKA22OSjDvhNI130_provenance.
- NP578918.RApsiWdr-kEHlbN0YVa6bMGQSw7Y0Iz-SKA22OSjDvhNI130_assertion wasGeneratedBy ECO_0000203 NP578918.RApsiWdr-kEHlbN0YVa6bMGQSw7Y0Iz-SKA22OSjDvhNI130_provenance.